HVEM is considered a “molecular switch” due to its ability to interact with either co-stimulatory or co-inhibitory receptors, providing the rationale for a dual role of BTLA/HVEM axis in CLL. This evidence concerns the gene BTLA and B-cell chronic lymphocytic leukemia.